To The Moon

$Lululemon Athletica(LULU)$’s shares already trade at a dramatically lower multiple than during the brand’s growth era. That alone does not create a turnaround. The September 3 earnings report must show that North American customers are responding to fresher products and that management can stabilise gross margin before incoming CEO Heidi O’Neill starts on September 8.

The company’s latest reported quarter ended May 3 and was released June 4. Revenue increased 4% to $2.47 billion, but constant-currency growth was only 2%. Americas revenue fell 3% and comparable sales declined 5%; international revenue increased 22%, including 30% growth in mainland China. The regional divergence shows that Lululemon still possesses global brand equity, but its largest market has become the problem.

Margins deteriorated faster than sales. Gross margin fell 410 basis points to 54.2%, operating income declined 37% to $276.9 million and diluted EPS dropped to $1.69 from $2.60. Management cut full-year guidance to $11.0–$11.15 billion of revenue—between a 1% decline and no growth—and EPS of $10.95–$11.15. It guided the July quarter to $2.45–$2.475 billion of revenue, down 3%–2%. Lululemon’s first-quarter filing with the SEC provides the results and guidance.

The bullish case is a clean balance sheet, international growth and low expectations. Lululemon ended the quarter with $1.5 billion of cash, repurchased $358 million of shares and held inventory dollars only 2% above the prior year even though unit inventory declined 4%. If new running, training and casual products restore full-price sales, margin recovery can generate substantial earnings leverage.

Heidi O’Neill’s appointment was announced on April 22, four and a half months before her September 8 start, giving her time to prepare a product and brand reset. The company’s CEO announcement confirms those dates.

The bearish case is that the weakness is competitive, not merely cyclical. Alo Yoga, Vuori, Nike and lower-priced alternatives have expanded choice, while Lululemon has acknowledged product-engine shortcomings. Tariffs and the removal of low-value import exemptions add costs at the same time that heavier markdowns may be needed to clear less desirable merchandise. International expansion cannot indefinitely offset a shrinking Americas base, and a new chief executive cannot redesign the assortment overnight.

Governance pressure is another catalyst. Shareholders backed the board slate on June 26 after the company reached an agreement with founder Chip Wilson, while Elliott Management had previously built a stake exceeding $1 billion and pushed for strategic change. Reuters’ June 26 report explains that context. The September 3 report therefore sets the baseline against which the new CEO and activist-influenced board will be judged. The company’s official events page confirms the reporting date.

$Lululemon Athletica(LULU)$ closed at $120.26 on August 31, down approximately 0.5%, after trading between $118.20 and $124.47. Volume of 13.65 million shares was roughly four times its recent average, unusually heavy immediately before earnings; the stock rose to approximately $120.90 after hours.

It remains down sharply during 2026 and only modestly above its $104.44 52-week low. Support is $118–$120, then $110–$112 and $104–$105. Resistance is $124–$125, followed by $135 and $145. The long-term trend remains bearish despite a possible base.

Selling premium before the September 3 report offers poor protection against a gap. If results confirm negative Americas comparable sales and LULU fails below $125 after implied volatility contracts, a 30–45-day $140/$150 bear call spread—or liquid strikes with the short call near 0.10–0.15 live delta above resistance—would define risk. A close above $135 supported by positive Americas comparable sales and sequential gross-margin improvement would invalidate the bearish structure. Maximum loss equals the $10 width minus the credit received.

The evidence leans bearish until the product and margin data improve. International growth and the balance sheet provide recovery potential, but declining Americas demand and a 410-basis-point gross-margin contraction are more important than the low share-price multiple. The view would be invalidated by positive North American comparable sales, full-price sell-through, sequential margin recovery and a sustained close above $135. This is personal opinion for education and is not financial advice; it is not an instruction to enter any trade.